EUVIMEDEUVIMED entdecken
Crossref

Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries

Joseph S Ross iD

New England Journal of Medicine · 06.02.2025 · 392 (6) · 521-523

DOI: 10.1056/nejmp2412955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 06.02.2025. Verfasst von Joseph S Ross. Beteiligte Einrichtung: Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Department of Health Policy and Management, Yale School of Public Health, New Haven, CT.
  • Center for Outcomes Research and Evaluation, Yale New Haven Health System, New Haven, CT.

ORCID-Profile: Joseph S Ross

Zitieren

APA

Ross, J. S. (2025). Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries. New England Journal of Medicine, 392(6), 521-523. https://doi.org/10.1056/nejmp2412955

Vancouver

Ross JS. Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries. New England Journal of Medicine. 2025;392(6):521-523. doi:10.1056/nejmp2412955

BibTeX
@article{Ross2025,
  author = {Ross, Joseph S},
  title = {Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {6},
  pages = {521--523},
  doi = {10.1056/nejmp2412955}
}
Kostenlos starten →